Fibromyalgia: Real-life Clinical Challenges CME

Stuart L. Silverman, MD, FACP, FACR Author Information and Disclosures

Release Date: May 2, 2008; Valid for credit through May 2, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

Contents of This CME Activity

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 education | outcomes | science
Pfizer
Learning Objectives
Upon completion of this activity, participants should be able to:
  1. Identify symptoms of fibromyalgia and distinguish fibromyalgia from clinically overlapping conditions.
  2. Analyze the benefits and adverse effects of current pharmacologic and nonpharmacologic therapies to alleviate symptoms of fibromyalgia.
  3. Effectively utilize multimodality therapy to treat fibromyalgia and its associated comorbidities.
  4. Understand clinical trial data for novel therapeutic approaches to fibromyalgia.
Author Disclosures
Stuart L. Silverman, MD, FACP, FACR
Disclosure: Grant/Research Support: Eli Lilly and Company, Merck & Co., Inc., Novartis, Procter & Gamble, Roche, Wyeth; Consultant: Merck & Co., Inc., Novartis, Procter & Gamble, Roche, Wyeth; Speaker: Eli Lilly and Company, Merck & Co., Inc., Procter & Gamble, Roche; Board of Directors: CompuMed

The staff of education | outcomes | science involved with this activity have reported no relevant financial relationships with commercial interests.
 
education | outcomes | science
education | outcomes | science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

education | outcomes | science designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The American Medical Association has determined that non-US licensed physicians who participate in this CME activity are eligible for AMA PRA Category 1 Credits™.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.